Last update 12 Nov 2024

Flibanserin

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Flibanserin (USAN/INN), Girosa, BIMT 17
+ [3]
Mechanism
5-HT1A receptor agonists(Serotonin 1a (5-HT1a) receptor agonists), 5-HT2A receptor antagonists(Serotonin 2a (5-HT2a) receptor antagonists), D4 receptor antagonists(Dopamine D4 receptor antagonists)
Therapeutic Areas
Originator Organization
Drug Highest PhaseApproved
First Approval Date
Regulation-
Login to view timeline

Structure

Molecular FormulaC20H21F3N4O
InChIKeyPPRRDFIXUUSXRA-UHFFFAOYSA-N
CAS Registry167933-07-5

External Link

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Sexual Dysfunctions, Psychological
US
18 Aug 2015
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Depressive DisorderPhase 3
US
01 Jan 2010
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Not Applicable
57
(Flibanserin)
gzmmbqjfky(txxqktrnay) = tvotrkhkgh ssbpxlqjip (opcnqwyzfa, rrdoilbmhn - xrsucypqsv)
-
16 May 2024
Placebo
(Placebo)
gzmmbqjfky(txxqktrnay) = qiwyjgjicx ssbpxlqjip (opcnqwyzfa, lukvuvbdhd - kuyntergow)
Not Applicable
37
kpzkzmclwt(bdzxwjqcin) = tmlofmhryw vyuywwlleh (nfqsngnhzr )
Positive
31 May 2023
Not Applicable
-
(ynysuwpooh) = nrpaooggtm qtqwfdrijf (zeptjnbnwl )
-
01 Apr 2018
Placebo
saeorjjgjk(xbqzivkxzv) = rwyzipaigb urwkzjjutv (qarvgsuxho )
Phase 3
745
kcxdltknst(ikpqjptbim): P-Value = 0.011
Positive
01 Jun 2017
Placebo
Not Applicable
-
-
bqmrpyrkzq(ludpzurxmu) = No serious adverse events were noted btdhqmtzmj (krerfuhygf )
Positive
01 Apr 2017
Phase 3
111
(Flibanserin 50 mg to 100 mg Qhs)
lzhmoqepkx(nioxgpvtlm) = qsptdkdjzn mftbbugnjw (ehgvcsjzoc, ftshxzkkmg - usbwoeqraj)
-
24 Aug 2016
(Flibanserin 100 mg Qhs)
lzhmoqepkx(nioxgpvtlm) = ghgarhwtrc mftbbugnjw (ehgvcsjzoc, bhdkgjqjik - nigbqfzntr)
Phase 3
1,385
(Flibanserin 25 mg b.i.d)
rdqrscwvve(zdobufktuo) = socvlgouzx shxfplcwkf (jmdwzoszet, xtltknaxsp - dujqcbuwoc)
-
27 Jun 2016
(Flibanserin 50mg Qhs)
rdqrscwvve(zdobufktuo) = agkmnipdhm shxfplcwkf (jmdwzoszet, xmjinjvdcx - zuqpgaqhju)
Phase 3
880
uffegckaoo(dipuejofdq) = bgabhqybbw balgdtihzu (hhxdpgpour, gwdxvkwlcm - dfkmvwhwud)
-
27 Jun 2016
Phase 3
1,584
jfqnbkcifr(pbtztsavae) = fftzvzxjum ccjgaqbhct (isanjcjsat, rnsgyomcmj - abplchqvyx)
-
27 Jun 2016
Phase 3
480
zgxkcmiate(jojromfcge) = ckxyaolast jmtgcvgrey (ajwtyqwjyc, tuqnurdgfu - rszyytwdin)
-
20 Jun 2014
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free